Chieh-Lin Jerry Teng, Yu-Min Liao, Bo-Wei Liao. "Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study." Blood (2025). https://doi.org/10.1182/blood-2025-5662